ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 39595083

Evaluation of the Impact of Advanced Glycation End-Products on Peripheral Neuropathy Outcomes in Type 2 Diabetes.

Singh I and 5 others. Biomedicines, 2024. Cited by 5 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Evaluation of the Impact of Advanced Glycation End-Products on Peripheral Neuropathy Outcomes in Type 2 Diabetes. Papers, record 39595083. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39595083

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Evaluation of the Impact of Advanced Glycation End-Products on Peripheral Neuropathy Outcomes in Type 2 Diabetes.
PubMed
Journal
Biomedicines
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
1.37, provisional
iCite
Revised in PubMed
2024-11-28
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Singh IIndumathi
2Issar TTushar
3Poynten AMAnn Mhttps://orcid.org/0000-0002-4373-6881
4Milner KLKerry-Lee
5Krishnan AVArun Vhttps://orcid.org/0000-0001-8883-8825
6Dhanapalaratnam RRoshanhttps://orcid.org/0000-0002-7684-0976

Source PubMed

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References30

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
131,471,200Measurement of axonal excitability: Consensus guidelines.Clin Neurophysiol2020https://conductscience.org/library/papers/31471200PubMed
223,625,758Reference values for nerve ultrasonography in the upper extremity.Muscle Nerve2013https://conductscience.org/library/papers/23625758PubMed
339,202,075Advancing the Diagnosis of Diabetic Neuropathies: Electrodiagnostic and Skin Autofluorescence Methods.J Pers Med2024https://conductscience.org/library/papers/39202075PubMed
426,897,744Inflammation as a Therapeutic Target for Diabetic Neuropathies.Curr Diab Rep2016https://conductscience.org/library/papers/26897744PubMed
522,608,666Diabetic neuropathy: clinical manifestations and current treatments.Lancet Neurol2012https://conductscience.org/library/papers/22608666PubMed
64,367,408Sensory conduction of the sural nerve in polyneuropathy.J Neurol Neurosurg Psychiatry1974https://conductscience.org/library/papers/4367408PubMed
711,742,414Biochemistry and molecular cell biology of diabetic complications.Nature2001https://conductscience.org/library/papers/11742414PubMed
824,286,947Advanced glycation endproducts in diabetes and diabetic complications.Endocrinol Metab Clin North Am2013https://conductscience.org/library/papers/24286947PubMed
919,317,818Reliability and validity of the modified Toronto Clinical Neuropathy Score in diabetic sensorimotor polyneuropathy.Diabet Med2009https://conductscience.org/library/papers/19317818PubMed
1011,514,239Excitability of human axons.Clin Neurophysiol2001https://conductscience.org/library/papers/11514239PubMed

1 to 10 of 30

See all 30 references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.

PMIDTitleJournalYearIn PapersSource
42,871,839Advanced Glycation End Products: From Pathogenesis to Treatment.MedComm (2020)2026https://conductscience.org/library/papers/42871839PubMed
42,851,444Metabolic and neuropathic outcomes following combined sodium-glucose cotransporter-2 inhibitor therapy and adjunctive acupuncture in obese patients with diabetic neuropathy: a case series.Front Pain Res (Lausanne)2026https://conductscience.org/library/papers/42851444PubMed
42,181,182Age and diabetic complications in type 2 diabetes: the role of disease duration and stage-dependent effects.Front Endocrinol (Lausanne)2026https://conductscience.org/library/papers/42181182PubMed
41,190,158Nutrient metabolism and complications of type 2 diabetes mellitus: implications for rehabilitation and precision care.Front Nutr2025https://conductscience.org/library/papers/41190158PubMed
41,179,869Skin manifestations in diabetes-what is new?Front Med (Lausanne)2025https://conductscience.org/library/papers/41179869PubMed

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
RENBP5,973PubTator's text mininghttps://conductscience.org/library/genes/5973

Source NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39595083

GET https://conductscience.org/api/papers/v1/39595083/references?page=2

API referenceFor AI assistants